Comerica Bank’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$1.28M Sell
7,337
-154,467
-95% -$28.2M 0.01% 1368
2025
Q3
$23.3M Sell
161,804
-70,595
-30% -$8.65M 0.09% 220
2025
Q2
$23.4M Sell
232,399
-57,876
-20% -$4.43M 0.09% 215
2025
Q1
$22.1M Buy
290,275
+119,495
+70% +$9.14M 0.09% 206
2024
Q4
$11.8M Buy
170,780
+108,686
+175% +$7.83M 0.05% 365
2024
Q3
$4.53M Buy
62,094
+8,319
+15% +$614K 0.02% 736
2024
Q2
$3.6M Buy
53,775
+4,235
+9% +$164K 0.02% 854
2024
Q1
$1.34M Buy
49,540
+48,327
+3,984% +$1.35M 0.01% 1370
2023
Q4
$37.6K Sell
1,213
-19
-2% -$493 ﹤0.01% 2802
2023
Q3
$31.1K Buy
+1,232
New +$28.2K ﹤0.01% 2849

Other funds holding INSM

Comerica Bank's INSM Position: Q4 2025 in Review

Comerica Bank reduced its Insmed (INSM) stake by 95% in Q4 2025, selling an estimated $28.2M and leaving 7,337 shares worth $1.28M. The position accounts for 0.01% of the portfolio, ranked #1368.

Comerica Bank first reported a position in INSM in Q3 2023 and has held it in 10 quarters since. The position peaked at $23.4M in Q2 2025. 677 funds tracked by Wall St. Rank hold INSM as of Q4 2025.

  • Comerica Bank held 7,337 shares of Insmed worth $1.28M as of Q4 2025.
  • Comerica Bank sold 154,467 Insmed shares in Q4 2025, an estimated $28.2M.
  • Insmed made up 0.01% of Comerica Bank's portfolio in Q4 2025, its #1368 holding.
  • Comerica Bank first reported a position in Insmed in Q3 2023 and has held it in 10 quarters since.
  • Comerica Bank's Insmed position peaked at $23.4M in Q2 2025.
  • 677 funds tracked by Wall St. Rank held Insmed as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.